Stefaan Allemeersch has been at the Centre for Drug Design and Discovery (CD3) since 2011. He has more than 20 years of broad experience in business development, corporate finance and marketing within the life sciences industry. Before joining CD3, he was a Director Healthcare, Corporate Finance & Capital Markets and Corporate Banking at Fortis/BNP Paribas. Prior to that, he held several positions at GlaxoSmithKline Biologics in Strategic Marketing, Tender Business and Business Development. He also served as Vice President Business Development at Kiadis Pharma. He holds an M.Sc. in bioengineering from KU Leuven (Belgium) and a Masters of Management from Vlekho Brussels.